Judith Kelleher-Andersson
Oprichter bij NeuroNascent, Inc.
Actieve functies van Judith Kelleher-Andersson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
NeuroNascent, Inc.
 NeuroNascent, Inc. Pharmaceuticals: MajorHealth Technology NeuroNascent, Inc. is an IND-enabling stage biopharmaceutical company that develops orally available, novel therapeutics aimed at halting or reversing chronic neurological disorders. It offers disease-modifying therapeutics for some of the most difficult to treat brain disorders that include Alzheimer's disease, Parkinson's disease, and Down syndrome. The Company is founded by Judith Kelleher-Andersson in May 2004 and is headquartered in Clarksville, MD. | Directeur/Bestuurslid | 01-01-2004 | - |
| Algemeen Directeur | 01-01-2004 | - | |
| Oprichter | 01-01-2004 | - | |
| President | 01-01-2004 | - | |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2004 | 01-01-2014 |
Loopbaan van Judith Kelleher-Andersson
Eerdere bekende functies van Judith Kelleher-Andersson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Centaur Pharmaceuticals, Inc. | Hoofd Techniek/Wetenschap/O&O | - | - |
| RESPIRERX PHARMACEUTICALS INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
| PALISADE BIO, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Judith Kelleher-Andersson
| University of Missouri | Doctorate Degree |
| University of California, Berkeley | Graduate Degree |
| St. Anselm College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
NeuroNascent, Inc.
NeuroNascent, Inc. Pharmaceuticals: MajorHealth Technology NeuroNascent, Inc. is an IND-enabling stage biopharmaceutical company that develops orally available, novel therapeutics aimed at halting or reversing chronic neurological disorders. It offers disease-modifying therapeutics for some of the most difficult to treat brain disorders that include Alzheimer's disease, Parkinson's disease, and Down syndrome. The Company is founded by Judith Kelleher-Andersson in May 2004 and is headquartered in Clarksville, MD. | Health Technology |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |
| Centaur Pharmaceuticals, Inc. | Health Technology |
